AlphaCrest Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-53,151
| Closed | -$698K | – | 1316 |
|
|
2020
Q4 | $698K | Buy |
53,151
+1,521
| +3% | +$20K | 0.06% | 475 |
|
|
2020
Q3 | $499K | Buy |
51,630
+33,212
| +180% | +$321K | 0.05% | 591 |
|
|
2020
Q2 | $211K | Sell |
18,418
-17,800
| -49% | -$204K | 0.04% | 821 |
|
|
2020
Q1 | $375K | Buy |
36,218
+13,307
| +58% | +$138K | 0.05% | 701 |
|
|
2019
Q4 | $376K | Sell |
22,911
-28,989
| -56% | -$476K | 0.03% | 947 |
|
|
2019
Q3 | $689K | Buy |
+51,900
| New | +$689K | 0.04% | 765 |
|
|
2019
Q2 | – | Sell |
-25,900
| Closed | -$477K | – | 1144 |
|
|
2019
Q1 | $477K | Buy |
+25,900
| New | +$477K | 0.07% | 480 |
|